Tag: edwards lifesciences

November 14, 2017

BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an...
June 16, 2017

Neovasc Shares Court in Case Against Edwards Lifesciences

Neovasc reported today the District Court in Munich, Germany has "partially found in favor" for Edwards Lifesciences Corporation in its...
April 25, 2017

BioSig Technologies Provides Shareholder Update

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address...
April 7, 2017

BioSig Technologies Completes Private Placement

BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address...
March 17, 2017

BioSig Technologies Announces Strategic Partnership with Mayo Clinic

BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP(TM) System, a proprietary platform designed to address an unmet...
October 14, 2016

BioSig's CEO on the Cardiac Device Market

We touched base with Greg Cash, CEO of BioSig Technologies, to hear his thoughts on the state of the market...